文献速递肝病炎症性肠病

原发性硬化性胆管炎患者粪便微生物组跨地域一致性改变

Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
PubMed 文献 · Aliment Pharmacol Ther · 2019-06-28

研究纳入德国和挪威388人(137例PSC、118例UC、133例健康对照),用16S rRNA基因测序分析粪便微生物组。两个队列中PSC患者与对照的微生物组成均有差异(P < 0.001),随机森林分类平均AUC为0.88;Proteobacteria和Parabacteroides增加跨地域可重复,合并结肠炎影响较小,提示PSC本身驱动微生物改变。

要点

  • PSC患者与健康对照的粪便微生物β多样性在德国和挪威两个队列中均存在差异(P < 0.001)。
  • 随机森林分类区分PSC患者与对照的平均AUC为0.88,跨两个地理队列。
  • Proteobacteria和耐胆盐的Parabacteroides增加跨地域可重复,且与是否合并结肠炎关系不大。

核心结论

  • 与健康对照相比,PSC患者中多种微生物群改变在不同地理区域可重复,提示微生物组成由疾病本身而非环境因素塑造。

研究设计与样本

  • 研究纳入来自德国和挪威的388名个体(中位年龄47岁,范围15-78岁),包括137例PSC患者(其中75例合并结肠炎)、118例溃疡性结肠炎患者和133例健康对照。
  • 采用16S rRNA基因测序(V1-V2区)分析粪便微生物组,对单个分类群的相对丰度差异进行meta分析。

主要发现

  • 在两个队列中,PSC患者与对照的微生物组成(β多样性)均存在差异(P < 0.001)。
  • 随机森林分类在两个地理队列中区分PSC患者与对照的平均AUC为0.88。
  • 与健康对照相比,PSC患者中鉴定出许多新的跨队列改变,如Proteobacteria和耐胆盐的Parabacteroides属增加,且这些改变与地理区域无关。
  • 合并结肠炎对微生物组成仅有较小影响,提示PSC本身驱动了观察到的粪便微生物群改变。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-centre studies reported alterations of faecal microbiota in patients with primary sclerosing cholangitis (PSC). As regional factors may affect microbial communities, it is unclear if a microbial signature of PSC exists across different geographical regions. AIM: To identify a robust microbial signature of PSC independent of geography and environmental influences. METHODS: We included 388 individuals (median age, 47 years; range, 15-78) from Germany and Norway in the study, 137 patients with PSC (n = 75 with colitis), 118 with ulcerative colitis (UC) and 133 healthy controls. Faecal microbiomes were analysed by 16S rRNA gene sequencing (V1-V2). Differences in relative abundances of single taxa were subjected to a meta-analysis. RESULTS: In both cohorts, microbiota composition (beta-diversity) differed between PSC patients and controls (P < 0.001). Random forests classification discriminated PSC patients from controls in both geographical cohorts with an average area under the curve of 0.88. Compared to healthy controls, many new cohort-spanning alterations were identified in PSC, such as an increase of Proteobacteria and the bile-tolerant genus Parabacteroides, which were detected independent from geographical region. Associated colitis only had minor effects on microbiota composition, suggesting that PSC itself drives the faecal microbiota changes observed. CONCLUSION: Compared to healthy controls, numerous microbiota alterations are reproducible in PSC patients across geographical regions, clearly pointing towards a microbiota composition that is shaped by the disease itself and not by environmental factors. These reproducibly altered microbial populations might provide future insights into the pathophysiology of PSC.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Rühlemann M, Liwinski T, Heinsen FA, et al. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Aliment Pharmacol Ther. 2019. PMID: 31250469. doi:10.1111/apt.15375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。